Ask anyone who’s had one: mammograms aren’t exactly a day at the spa. They’re life-saving, essential—and usually uncomfortable. But this week, we’ve got some good news worth celebrating, as groundbreaking technology is changing the game in breast cancer screening.
Meet Koning Vera Breast CT—a new imaging system that’s making early breast cancer detection not just more accurate but also far more comfortable.
What’s the Big Deal?
Developed by Georgia-based Koning Health, the Koning Vera Breast CT delivers crystal-clear, true 3D images in just seven seconds. Unlike traditional mammograms, there’s no uncomfortable compression, making it a gentler experience.
More importantly, the quality of imaging is vastly superior. As explained by Koning Health’s CEO Lutao Ning:
“We are thrilled to see our technology being embraced by health care providers globally. Our recent and upcoming installations are a clear indication of the impact the Koning Vera is making in the fight against breast cancer. We remain dedicated to pushing the boundaries of what’s possible in breast imaging and ensuring that more women have access to the lifesaving diagnostics they deserve.”
Why This Matters
The Vera Breast CT is especially helpful for women with dense breast tissue, a condition that slightly increases breast cancer risk but significantly complicates diagnosis through regular mammograms.
Unlike digital breast tomosynthesis (DBT), which creates a layered image from multiple 2D scans, Vera CT is truly 3D. According to Koning Health:
“Breast CT is true 3D—the image can be viewed from any angle equally, which eliminates any overlapping structures.”
This means fewer false alarms, clearer diagnoses, and faster peace of mind.
Growing Accessibility
The Koning Vera Breast CT has been installed in several prominent locations:
- Bedford Breast Center in Beverly Hills, California
- Community Radiology NY in Manhattan, New York
- Clinical availability in Arkansas, Alabama, Georgia, Tennessee, Europe, and Asia
- New installations planned soon for Texas, Illinois, Florida, and Ohio
FDA Approved & Insurance Supported
First developed in 2006, the device underwent rigorous testing before securing FDA approval in 2017. By 2020, it gained official recognition from the American Medical Association, enabling insurance billing, further expanding accessibility for patients everywhere .
Bottom Line: A Step Forward in Women’s Health
This advancement doesn’t mean mammograms are out—they’re still critically important. But this new technology offers an additional tool that’s less stressful, more accurate, and ultimately empowering.
As Koning Health continues to roll out their innovative technology worldwide, the future looks brighter—and more comfortable—for breast cancer screening.
And in our Hopium Health book, that’s definitely some Nice News worth sharing.
— Kumar Da & the Hopium Health Team
